Haemonetics Corp. buy BTIG Research
Start price
21.11.25
/
50%
€67.50
Target price
21.11.26
€76.29
Performance (%)
37.78%
Price
20.08.26
€93.00
Summary
This prediction is currently active. With a performance of 37.78% the BUY prediction by BTIG_Research is a big success. This prediction currently runs until 21.11.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 16.981% | 16.981% |
| iShares Core DAX® | -1,59 % | 5,03 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % |
| iShares S&P 500 | -3,23 % | 0,47 % |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€74.00
06.08.26
06.08.26
€83.10
06.08.27
06.08.27
25.68%
20.08.26
20.08.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€68.00
26.06.26
26.06.26
€73.86
26.06.27
26.06.27
36.76%
20.08.26
20.08.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€64.00
17.06.26
17.06.26
€72.34
17.06.27
17.06.27
45.31%
20.08.26
20.08.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€48.40
06.02.26
06.02.26
€74.64
06.02.27
06.02.27
92.15%
20.08.26
20.08.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€72.00
09.01.26
09.01.26
€75.54
09.01.27
09.01.27
29.17%
20.08.26
20.08.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.50
06.11.25
06.11.25
€76.46
06.11.26
06.11.26
61.74%
20.08.26
20.08.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.50
10.09.24
10.09.24
€101.52
10.09.25
10.09.25
-32.03%
11.09.25
11.09.25

